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Background
Although the use of anti retroviral drugs has prolonged
the life of infected patients, the side effects can be severe.
The objective of this work is to efficiently estimate the
optimal drug dosage for ART using mathematical model
based method.
Methods
In this work, an artificial intelligence technique known
as the hybrid Bacterial Foraging Particle Swarm Optimi-
zation (BFPSO) algorithm is used in conjunction with
the three dimensional patient specific HIV model, for
estimation of optimal drug concentration. In the mathe-
matical model, it is assumed that the drug acts directly
on the viral burden. The optimization problem is formu-
lated in such a way that the HIV-1 viral load as well as
the total drug concentration is minimized.
Results
Based on the computer simulation studies performed for a
particular case at the seventh year of infection, it was found
that in the scenario without therapy, the CD4 cell count
dropped to a value of 366 cells/mm3. However, when ART
is administered based on the hybrid BFPSO algorithm, the
CD4 cell count increased to a value of 782 cells/mm3, with
minimal usage of the drug concentration.
Conclusion
Results demonstrate that, the optimal drug dosage esti-
mated using the proposed methodology is efficient in
improving the immune system and minimizing the viral
burden. This work seems to be of high clinical importance
since, at present; ART is the widely used method for treat-
ment of HIV-1 infection.
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